Compugen Stock

Compugen P/B

Delisted·Jun 15, 2026

The P/B (Price-to-Book Ratio) of Compugen (CGEN) as of Jul 17, 2026 is 1.94. In the previous year, P/B (Price-to-Book Ratio) was 3.63 — a change of -46.55% (lower).

P/B

1.94

YoY

-46.55%

Last updated:

P/B (Price-to-Book Ratio) of Compugen is 2026 1.94 . P/B (Price-to-Book Ratio) of Compugen was 2025 3.63 . It decreases by -46.55% lower compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

P/B (Price-to-Book Ratio) of Compugen is 1.94 in 2026.

Access this data via the Eulerpool API

Valuation — Compugen

All Key Metrics — Compugen